Pharmacoeconomic analysis of cefmenoxime dual individualization in the treatment of nosocomial pneumonia.

@article{Paladino1994PharmacoeconomicAO,
  title={Pharmacoeconomic analysis of cefmenoxime dual individualization in the treatment of nosocomial pneumonia.},
  author={Joseph A. Paladino and Rona Fell},
  journal={The Annals of pharmacotherapy},
  year={1994},
  volume={28 3},
  pages={384-9}
}
OBJECTIVE To determine if dual individualization of cefmenoxime dosing is cost-effective. DESIGN Retrospective, pharmacoeconomic decision analysis of two consecutively conducted prospective clinical studies. PATIENTS Patients with documented gram-negative nosocomial pneumonia were evaluated. Thirty-three patients received cefmenoxime at standard dosing and 28 patients received doses according to dual individualization methodology. MAIN OUTCOME MEASURE Antibiotic and infection-related… CONTINUE READING